ArticlePlant biotechnology journal2026
ZmWRKY29 Transcriptionally Represses ZmRBOHC to Attenuate ROS Production and Facilitates Gibberella Stalk Rot Susceptibility in Maize.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Gibberella stalk rot (GSR), caused by the fungal pathogen Fusarium graminearum, severely threatens maize production. However, the molecular mechanisms underlying maize resistance to GSR remain poorly understood. Here, we have identified ZmWRKY29 as a transcriptional repressor induced by F. graminearum infection, which negatively regulates maize resistance to GSR. Overexpression of ZmWRKY29 significantly compromised GSR resistance with a marked reduction in reactive oxygen species (ROS) production and callose deposition, while its mutation enhanced resistance and elevated ROS accumulation. RNA-seq revealed that the expression levels of two respiratory burst oxidase homologues, ZmRBOHA and ZmRBOHC, were decreased in ZmWRKY29-OE lines following F. graminearum challenge. ZmWRKY29 directly binds to the W-boxes in the promoters of ZmRBOHA and ZmRBOHC to repress their transcription. Moreover, mutation of ZmRBOHC similarly led to increased susceptibility and diminished ROS accumulation, confirming that ZmWRKY29-targeted ZmRBOHC is required for ROS production and GSR resistance. Thus, ZmWRKY29 acts as a susceptibility factor, repressing GSR resistance possibly by inhibiting ZmRBOHC-mediated ROS production. This highlights a pathogen strategy of exploiting host transcriptional machinery to suppress ROS defences and facilitate infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.